10/06/21 HighCape Capital Acquisition : Quantum-Si Completes Merger With HighCape Capital Acqusition MT
10/06/21 HighCape Capital Acquisition Corp.(NasdaqCM:CAPA) dropped from NASDAQ Composite Index CI
10/06/21 Quantum-Si incorporated completed the acquired the acquisition of HighCape Capital Acquisition Corp. from HighCape Partners Management, L.P. and others in a reverse merger transaction. CI
25/05/21 Highcape Capital Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
02/03/21 Certain Class B Common Stock of HighCape Capital Acquisition Corp. are subject to a Lock-Up Agreement Ending on 2-MAR-2021. CI
18/02/21 HighCape Capital Acquisition : Quantum-Si to Go Public Via Merger With HighCape Capital Acquisition Corp. MT
18/02/21 HighCape Capital Acquisition : Protein sequencing firm Quantum-Si to go public via $1.46 bln SPAC merger RE
18/02/21 Quantum-Si incorporated entered into a non-binding letter of intent to acquire HighCape Capital Acquisition Corp. from HighCape Partners Management, L.P. and others for approximately $920 million in a reverse merger transaction. CI
07/11/20 HighCape Capital Acquisition Corp.(NasdaqCM:CAPA) added to NASDAQ Composite Index CI
09/09/20 HighCape Capital Acquisition Corp. Announces Executive Appointments CI
09/09/20 HighCape Capital Acquisition Corp. announced that it has received $4.05 million in funding from HighCape Capital Acquisition LLC CI
03/09/20 HighCape Capital Acquisition Corp. has completed an IPO in the amount of $100 million. CI
03/08/20 HighCape Capital Acquisition Corp. has filed an IPO in the amount of $100 million. CI
Date Insider Type Main position Quantity % Market Cap. Importance
9/3/20 A Other

Director

30,000 1.0435%
9/3/20 A Other

Director

30,000 1.0435%
9/3/20 A Other

Chief Financial Officer

2,785,000 96.8696%
Logo HIGE CAPI
Quantum-SI Incorporated (Quantum-SI), formerly HighCape Capital Acquisition Corp., is focused on semiconductor chip-based proteomics. The Company offers end-to-end, universal single molecule detection solution. The Company's suite of technologies is powered by semiconductor chip designed to enable single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics. Quantum-SI's Time Domain Sequencing technology removes the dependency on color as an identification method, a hurdle for any application outside of genomics where only four colors are needed. The Company has created a single-molecule proteomics and genomics platform with the goal of revolutionizing the growing field of proteomics. The Company's semiconductor chip has the power to decode the molecules of life, starting with proteins, and holds the potential to expand the scale of the genomics and proteomics market.
Employees
-
Sector
-
  1. Stock Market
  2. Stocks
  3. CAPA Stock